Open AccessCorrection: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
Author(s) -
Mark Merchant,
John G. Moffat,
Gabriele Schaefer,
Jocelyn Chan,
Xi Wang,
Christine Orr,
Jason H. Cheng,
Thomas Hunsaker,
Lily Shao,
Stephanie J. Wang,
Marie-Claire Wagle,
Eva Lin,
Peter M. Haverty,
Sheerin Shahidi-Latham,
Hai Ngu,
Margaret Solon,
Jeffrey Eastham-Anderson,
Hartmut Koeppen,
Shih-Min A. Huang,
Jacob B. Schwarz,
Marcia Belvin,
Daniel C. Kirouac,
Melissa R. Junttila
Publication year - 2018
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0192059
Subject(s) - mapk/erk pathway , mutant , medicine , bioinformatics , cancer research , biology , microbiology and biotechnology , genetics , signal transduction , gene